UBS Group Has Lowered Expectations for Xylem (NYSE:XYL) Stock Price

Xylem (NYSE:XYLGet Free Report) had its target price lowered by equities researchers at UBS Group from $155.00 to $152.00 in a note issued to investors on Thursday,Benzinga reports. The firm currently has a “buy” rating on the industrial products company’s stock. UBS Group’s price objective suggests a potential upside of 17.31% from the company’s previous close.

Several other equities analysts also recently issued reports on XYL. Weiss Ratings downgraded shares of Xylem from a “buy (b-)” rating to a “hold (c+)” rating in a report on Monday. TD Cowen reaffirmed a “hold” rating on shares of Xylem in a research note on Monday, February 23rd. Citigroup dropped their target price on shares of Xylem from $182.00 to $174.00 and set a “buy” rating for the company in a research note on Wednesday, February 11th. Barclays dropped their target price on shares of Xylem from $166.00 to $156.00 and set an “overweight” rating for the company in a research note on Wednesday, February 11th. Finally, Oppenheimer reaffirmed an “outperform” rating and issued a $160.00 target price (down from $165.00) on shares of Xylem in a research note on Wednesday, April 1st. Nine analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $155.31.

View Our Latest Report on XYL

Xylem Price Performance

XYL stock traded up $1.60 during trading on Thursday, hitting $129.57. 2,303,585 shares of the stock traded hands, compared to its average volume of 1,921,745. Xylem has a one year low of $104.14 and a one year high of $154.27. The stock has a market cap of $31.50 billion, a price-to-earnings ratio of 33.05, a P/E/G ratio of 1.74 and a beta of 1.18. The company has a 50 day simple moving average of $126.74 and a 200 day simple moving average of $137.35. The company has a current ratio of 1.62, a quick ratio of 1.28 and a debt-to-equity ratio of 0.12.

Xylem (NYSE:XYLGet Free Report) last announced its quarterly earnings results on Tuesday, February 10th. The industrial products company reported $1.42 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.42. Xylem had a net margin of 10.59% and a return on equity of 11.11%. During the same quarter in the prior year, the company posted $1.18 earnings per share. The firm’s revenue was up 6.3% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.350-5.560 EPS. Equities analysts expect that Xylem will post 4.65 EPS for the current fiscal year.

Xylem announced that its board has authorized a share buyback program on Wednesday, February 25th that allows the company to buyback $1.50 billion in shares. This buyback authorization allows the industrial products company to purchase up to 4.8% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s board of directors believes its stock is undervalued.

Institutional Investors Weigh In On Xylem

Institutional investors and hedge funds have recently modified their holdings of the business. SJS Investment Consulting Inc. raised its stake in shares of Xylem by 1,844.4% during the third quarter. SJS Investment Consulting Inc. now owns 175 shares of the industrial products company’s stock worth $26,000 after buying an additional 166 shares during the last quarter. Knuff & Co LLC bought a new stake in shares of Xylem during the third quarter worth approximately $27,000. Board of the Pension Protection Fund bought a new stake in shares of Xylem during the fourth quarter worth approximately $27,000. Commonwealth Retirement Investments LLC bought a new stake in shares of Xylem during the fourth quarter worth approximately $27,000. Finally, Wexford Capital LP bought a new stake in shares of Xylem during the third quarter worth approximately $27,000. 87.96% of the stock is owned by institutional investors.

Xylem Company Profile

(Get Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

See Also

Analyst Recommendations for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.